Advertisement

Topics

Dyax Company Profile

08:17 EST 24th November 2017 | BioPortfolio

Dyax is developing and commercializing new products for the pharmaceutical and biopharmaceutical industries. We discover and develop products using Dyax's two technology platforms:

Phage Display Binding Technology

Rapid identification of proteins, peptides and human antibodies for all applications

High throughput discovery of high affinity target-binding molecules

Greater diversity than any combinatorial chemistry method



Separations Products Platform

Chromatography systems and products sold under the Biotage™ tradename, providing timely, cost-effective solutions to the changing purification needs of the biopharmaceutical and traditional pharmaceuticals industries.

Location

300 Technology Square
Cambridge
MA
02139
United States of America

Contact

Phone: 617 225 2500
Fax: 617 225 2501
Email: thrapeutics@dyax.com


News Articles [3 Associated News Articles listed on BioPortfolio]

Dyax Corp. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15062017] Prices from USD $350

Dyax Corp. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Dyax Corp. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes busi...

PTV News: Dec 3, 2009

Top stories on December 3rd, 2009: AZ in billion dollar deal for Targacept's antidepressant Roche's diabetes drug "better than Merck's Januvia" Dyax shares skyrocket on FDA approval of Kalbitor ...

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetratin...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Kalbitor [Dyax Corp.]

These highlights do not include all the information needed to use KALBITOR safely and effectively. See full prescribing information for KALBITOR. KALBITOR (ecallantide) Injection for subcutaneous use ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Dyax Corp.

Dyax is a fully integrated biopharmaceutical company focused on discovering, developing and commercializing novel biotherapeutics for unmet medical needs. Dyax utilizes its propri...

Dyax

Dyax is developing and commercializing new products for the pharmaceutical and biopharmaceutical industries. We discover and develop products using Dyax's two technology platforms: Phage Display B...

Zenyth Therapeutics Limited

Zenyth Therapeutics Limited (Zenyth) is a public listed (ASX: ZTL) Australian biotechnology company primarily focused on the development and commercialisation of antibody-based therapies in the areas ...

BioCatalyst International

BioCatalyst is a group of experienced business and scientific entrepreneurs who are focused on transitioning a scientifically validated product to an accepted product in the marketplace. BioCatalyst i...

More Information about "Dyax" on BioPortfolio

We have published hundreds of Dyax news stories on BioPortfolio along with dozens of Dyax Clinical Trials and PubMed Articles about Dyax for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dyax Companies in our database. You can also find out about relevant Dyax Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record